UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fibrinolysis and bleeding of unknown cause

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12511-n/a, Article e12511

2021

Volltextzugriff (PDF)

P1625: CLINICAL AND LABORATORY CHARACTERISTICS OF ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN EASTERN AUSTRIA

HemaSphere, 2023-08, Vol.7 (S3), p.e4496821-n/a

2023

Volltextzugriff (PDF)

P1623: LOW LEVELS OF 25(OH) VITAMIN D IN ADULT PRIMARY ITP PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e3847359-n/a

2023

Volltextzugriff (PDF)

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion

Hamostaseologie, 2024-08, Vol.44 (4), p.287-297

2024

Volltextzugriff (PDF)

Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause

Hämostaseologie, 2024-10, Vol.44 (5), p.358-367

2024

Volltextzugriff (PDF)

Natural anticoagulants: A missing link in mild to moderate bleeding tendencies

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-09, Vol.27 (5), p.701-709

2021

Volltextzugriff (PDF)

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1757-1768

2023

Volltextzugriff (PDF)

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Blood, 2022-11, Vol.140 (Supplement 1), p.8433-8434

2022

Volltextzugriff (PDF)

Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out

Research and practice in thrombosis and haemostasis, 2023-11, Vol.7 (8), p.102242-102242, Article 102242

2023

Volltextzugriff (PDF)

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

Journal of thrombosis and haemostasis, 2024-01, Vol.22 (1), p.101-111

2024

Volltextzugriff (PDF)

Utility of the Platelet Function Analyzer (PFA-100) in Patients with Bleeding Disorder of Unknown Cause

Blood, 2023-11, Vol.142 (Supplement 1), p.3965-3965

2023

Volltextzugriff (PDF)

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Blood, 2023-11, Vol.142 (Supplement 1), p.1208-1208

2023

Volltextzugriff (PDF)

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Thrombosis research, 2024-03, Vol.235, p.98-106

2024

Volltextzugriff (PDF)

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Blood, 2023-11, Vol.142 (Supplement 1), p.1249-1249

2023

Volltextzugriff (PDF)

Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP)

Blood, 2021-11, Vol.138 (Supplement 1), p.3162-3162

2021

Volltextzugriff (PDF)

Thrombomodulin in patients with mild to moderate bleeding tendency

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.1028-1036

2021

Volltextzugriff (PDF)

Fibrinolysis is impaired in patients with primary immune thrombocytopenia

Journal of thrombosis and haemostasis, 2024-11, Vol.22 (11), p.3209-3220

2024

Volltextzugriff (PDF)

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Thrombosis research, 2023-03, Vol.223, p.102-110

2023

Volltextzugriff (PDF)

Health-related quality of life is impaired in bleeding disorders of unknown cause: results from the Vienna Bleeding Biobank

Research and practice in thrombosis and haemostasis, 2023-08, Vol.7 (6), p.102176-102176, Article 102176

2023

Volltextzugriff (PDF)

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Blood, 2020-11, Vol.136 (Supplement 1), p.16-18

2020

Volltextzugriff (PDF)

Hemostatic biomarkers associated with postpartum hemorrhage: a systematic review and meta-analysis

Blood advances, 2023-10, Vol.7 (19), p.5954-5967

2023

Volltextzugriff (PDF)

Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause

Blood advances, 2020-10, Vol.4 (20), p.5157-5164

2020

Volltextzugriff (PDF)

Hemostatic biomarkers associated with postpartum hemorrhage: a systematic review and meta-analyses

Blood advances, 2023-06

2023

Volltextzugriff (PDF)

Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency

Blood advances, 2021-01, Vol.5 (2), p.391-398

2021

Volltextzugriff (PDF)

Plasmin generation analysis in patients with bleeding disorder of unknown cause

Blood advances, 2024-11, Vol.8 (21), p.5663-5673

2024

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Fibrinolysis and bleeding of unknown cause

P1625: CLINICAL AND LABORATORY CHARACTERISTICS OF ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN EASTERN AUSTRIA

P1623: LOW LEVELS OF 25(OH) VITAMIN D IN ADULT PRIMARY ITP PATIENTS

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion

Utility of Global Hemostatic Assays in Patients with Bleeding Disorders of Unknown Cause

Natural anticoagulants: A missing link in mild to moderate bleeding tendencies

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

Utility of the Platelet Function Analyzer (PFA-100) in Patients with Bleeding Disorder of Unknown Cause

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Impact of Blood Group O and Von Willebrand Factor on Bleeding Severity in Patients with Von Willebrand Disease and Bleeding Disorder of Unknown Cause

Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP)

Thrombomodulin in patients with mild to moderate bleeding tendency

Fibrinolysis is impaired in patients with primary immune thrombocytopenia

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Health-related quality of life is impaired in bleeding disorders of unknown cause: results from the Vienna Bleeding Biobank

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Hemostatic biomarkers associated with postpartum hemorrhage: a systematic review and meta-analysis

Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause

Hemostatic biomarkers associated with postpartum hemorrhage: a systematic review and meta-analyses

Elevated levels of tissue factor pathway inhibitor in patients with mild to moderate bleeding tendency

Plasmin generation analysis in patients with bleeding disorder of unknown cause

Suchergebnisse filtern